Merck’s Capvaxive Seeks to Become the Primary Shot for Pneumococcal Disease Prevention
Capvaxive covers roughly 84% of serotypes responsible for pneumococcal disease in adults 50 years and older. Capvaxive is non-inferior to ...
Tag: Merck
Mixed results regarding finasteride for prostate cancer prevention
Image: PD 1. Finasteride reduces the risk of developing prostate cancer overall, but increases risk for high-grade prostate cancer. 2. ...